Editorial: proactive anti-TNF drug monitoring in IBD-Ready for the prime time? Authors' reply

Aliment Pharmacol Ther. 2023 Jun;57(12):1455-1456. doi: 10.1111/apt.17339.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Drug Monitoring
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Tumor Necrosis Factor Inhibitors*

Substances

  • Tumor Necrosis Factor Inhibitors